HL Pharma is pleased to announce it is partnering with Novartis Australia to supply one of their ophthalmic products under The Special Access Scheme or Authorised Prescriber Scheme. This is until the Australian registered product becomes available.
Glanatec (ripasudil) 0.4% Eye Drops Ripasudil is a Rho Kinase inhibitor, licensed in Japan. This product is not registered in Australia and is available for supply under The Special Access Scheme (SAS) C
A Section 19a approval is no longer available for the supply Dexafree. Dexafree continues to be available under SAS C if required. Please contact us to find out more about information on this product.
Phenelzine (Nardil) 15mg Tablets have been discounted in Australia. Phenelzine is still available from overseas. HL Pharma can arrange supply of Phenelzine 15mg Tablets from overseas under various TGA approved processes. If you are a patient, please ask your pharmacist to get in touch with us as we are only [...]